UltraGreen.ai calls itself a global leader in the fluorescence-guided surgery space. Its niche, albeit a growing one, is to pioneer AI tools for precision surgery using data-driven fluorescence imaging solutions. UltraGreen.ai offers a fluorescence imaging ecosystem — built around the Indocyanine green (ICG) fluorescent dye — that enables surgeons to achieve greater precision with real-time perfusion data, ultimately improving patient outcomes.
UltraGreen.ai has been listed on the Singapore Exchange (SGX) as one of the larger healthcare-related names, injecting some variety into the local bourse, which has been dominated by companies in financial services, property and REITs.
In his own words, Ravinder Sajwan, CEO and executive director of the company, says his background has been in technology rather than healthcare. However, it is now at the intersection of these two fields where he is making his mark.
